In good health: Wider recognition and increasing health reforms will support the industry

The use of medication for the treatment of attention deficit disorders, such as ADHD, is growing. The recent recognition of ADHD as a condition that can also afflict adults has provided a boon to the industry, and healthcare reform has enabled more children to access behavioral health services, resulting in more patients being able to have their ADHD identified and treated. In the five years to 2021, industry revenue will continue to grow as the trends from the previous five years bolster utilization rates. However, many brand-name drugs are set to lose their patent exclusivity, which will incite more generic drug manufacturers to inundate the market with low-cost drugs, intensifying price-based competition...read more.

Industry Statistics & Market Size
Revenue
$13bn
Annual Growth 11-16
5.2%
Forecast Growth 16-21
Profit
Employment
13,216
Businesses
233
Market Share of Companies
What Our Customers Say

Industry Threats & Opportunities

  • Healthcare reform will enable more children to access behavioral health services
  • Demand for ADHD drugs increased as more individuals acquired private health insurance
  • As ADHD drugs become accepted internationally, industry exports are expected to increase
  • Industry Report - Industry Locations Chapter

    The business location chart below reflects the distribution of pharmaceutical manufacturers in the United States; producers of ADHD medications for the most part mirror this distribution, as most ADHD medication manufacturers also make other pharmaceutical products. ADHD medication manufacturers, like all pharmaceutical manufacturers, will benefit from being located near both upstream research and development talent pools and downstream markets such as pharmaceutical distributors and hospitals. As a result, a significant number of manufacturers are located in highly populous states, such as New York and California, which attract large customer bases. Sim...purchase to read more.

    Additional Insights for the ADHD Medication Manufacturing Industry

    IBISWorld identifies 250 Key Success Factors for a business.The most important for the ADHD Medication Manufacturing Industry are

  • Must comply with required product standards
  • Establishment of brand names
  • Fast adjustments made to changing regulations
  • IBISWorld analysts also discuss how external factors such as Federal funding for Medicare and Medicaid and Number of people with private health insurance in the ADHD Medication Manufacturing industry impact industry performance..

    shopping_cartPURCHASE OPTIONS

    Table of Contents

    Industry Definition
    Main Activities
    Similar Industries
    Additional Resources
    Industry Statistics Snapshot
    Industry Structure
    Executive Summary
    Executive Summary
    Key External Drivers
  • Federal funding for Medicare and Medicaid
  • Number of people with private health insurance
  • Number of children aged nine and younger
  • Research and development expenditure
  • Trade-weighted index

  • Current Performance
    ADHD demographic trendsHealthcare reform
  • Chart: Revenue Growth

  • Industry Outlook
    Adult ADHD boosts demandHealthcare reform
  • Table: ADHD Medication Manufacturing Industry Revenue Outlook

  • Industry Life Cycle
  • Life cycle reasons
  • Chart: Benchmarking - ADHD Medication Manufacturing Industry Lifecycle vs The Economy

  • Supply Chains
    Key Buying Industries
  • Pharmacies & Drug Stores
  • Mental Health & Substance Abuse Clinics
  • Hospitals
  • Psychiatric Hospitals
  • Residential Intellectual Disability Facilities

  • Key Selling Industries
  • Biotechnology
  • Inorganic Chemical Manufacturing
  • Medical Instrument & Supply Manufacturing
  • Organic Chemical Manufacturing
  • Soap & Cleaning Compound Manufacturing

  • Products & Services
  • Amphetamine and dextroamphetamine medications
  • Lisdexamfetamine medications
  • Methylphenidate and dexmethylphenidate medications
  • Chart: ADHD Medication Manufacturing Industry Products and Services Segmentation

  • Demand Determinants
    Major Markets
  • Individuals aged 18 and older
  • Children aged 12 and younger
  • Children aged 13 to 17
  • Chart: Major Market Segmentation for the ADHD Medication Manufacturing Industry

  • International Trade
    Business Locations
    Chart: Business Locations by State
    Market Share Concentration
    Key Success Factors
    Cost Structure Benchmarks
    ProfitPurchasesWagesOther costs
  • Chart: Cost Structure Benchmarking – Sector vs ADHD Medication Manufacturing

  • Basis of Competition
    Internal competitionExternal competition
    Barriers to Entry
  • Table: Barrier to Entry Checklist for the ADHD Medication Manufacturing Industry

  • Industry Globalization
    Shire Pharmaceuticals
  • Table: Shire Pharmaceuticals - financial performance

  • Capital Intensity
  • Chart: Level of Capital Intensity for the ADHD Medication Manufacturing Industry
  • Chart: Tools of the Trade: Growth Strategies for Success

  • Technology & Systems
    Revenue Volatility
  • Chart: Volatility vs Industry Growth

  • Regulation & Policy
    Industry Assistance
    Table: Industry Data for the ADHD Medication Manufacturing Industry
    Includes:
  • Industry Revenue (2007-2021)
  • Industry Gross Product (2007-2021)
  • Establishments (2007-2021)
  • Businesses (2007-2021)
  • Employment (2007-2021)
  • Exports (2007-2021)
  • Imports (2007-2021)
  • Wages (2007-2021)
  • Number of people with private health insurance (2007-2021)

  • Table: Annual Percentage Change for Key Industry Data
    Table: Key Ratios for Industry Key Data
    Abbreviated New Drug Application (Anda)
  • An application for the approval of a generic drug where manufacturers must scientifically prove that their products are bioequivalent to the brand products.
  • New Drug Application (Nda)
  • An application filed for the approval of a new drug product. Once approved, the product may be marketed in the United States.
  • Patent Cliff
  • The period when numerous patents on blockbuster drugs are set to expire.
  • Why buy this report?

    The ADHD Medication Manufacturing Industry Research Report measures market size, analyses current and future trends, and provides an indication of market share for the industry’s largest companies. IBISWorld’s collection of industry market research reports gives you insightful, up-to-date information on the supply chains, economic drivers, and key buyers and markets for hundreds of industries.

    IBISWorld industry market research reports enable you to:
    • Find out about key industry trends
    • Identify threats and opportunities
    • Inform your decisions for marketing, strategy and planning
    • Quickly build competitive intelligence
    This report on ADHD Medication Manufacturing:
    • Provides Market Size information to assist with planning and strategic decisions.
    • Includes the necessary information to perform SWOT, PEST and STEER analysis.
    • Helps you understand market dynamics to give you a deeper understanding of industry competition and the supply chain.
    • Analyses key performance and operational metrics so that you can benchmark against your own business, that of your customers’ businesses, or your competitors’ businesses.
    The ADHD Medication Manufacturing market research report includes:
    • Historical data and analysis for the key drivers of this industry
    • A five-year forecast of the market and noted trends
    • Detailed research and segmentation for the main products and markets
    • An assessment of the competitive landscape and market shares for major companies
    • And of course, much more

    IBISWorld reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on industry trends across all industries. With this IBISWorld Industry Research Report on ADHD Medication Manufacturing, you can expect thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

    Contact Us

    Want to speak to a representative? Call us.

    clear